Cytodyn Inc (CYDY)

[DonDonDonDon]

He told me RLFTF (Avditapl) is two weeks behind CYDY putting out data

RLFTF's trial was supposed to end in early January but the FDA added 31 patients and a few weeks to their trial. Their trial now finishes Jan 21st. My guess is that the FDA added the patients and time because they wanted to look at the data at the same time as CYDY's data. So maybe only one will get an EUA. RLF-100 has far more impressive results from their eINDS than leronlimab. And RLFTF isn't run by an incompetent, corrupt buffoon like Nader so it'll go to RLFTF if the data are close. It shouldn't be a difficult choice. But the people in here believe in leronlimab with a religious fervor so they'll never even consider that a possibility.